| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $4.27B | +4.9% |
| R&D Expense | $782.7M | -11.5% |
| SG&A Expense | $1.81B | +30.6% |
| Operating Income | -$430.2M | -160.0% |
| Pre-tax Income | -$627.9M | -233.5% |
| Income Tax | -$272.4M | -198.0% |
| Net Income | -$356.1M | -163.6% |
| EPS (Basic) | -$5.84 | -164.5% |
| EPS (Diluted) | -$5.84 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.39B | -42.3% |
| Accounts Receivable | $830.7M | +15.9% |
| Inventory | $417.0M | -13.2% |
| Current Assets | $4.17B | -10.0% |
| Total Assets | $11.66B | -2.9% |
| Current Liabilities | $2.24B | +115.9% |
| Long-term Debt | $5.36B | -12.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.36B | -2.9% |
| Capital Expenditures | $58.8M | +54.3% |
| Investing Cash Flow | -$1.51B | -197.1% |
| Financing Cash Flow | -$873.4M | -4357.1% |
| Free Cash Flow | $1.30B | -4.5% |
| -167.5% |
| Stockholders' Equity |
| $4.32B |
| +5.5% |